Literature DB >> 27500496

A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

Vivian Zhou, Kimberle Agle, Xiao Chen, Amy Beres, Richard Komorowski, Ludovic Belle, Carolyn Taylor, Fenlu Zhu, Dipica Haribhai, Calvin B Williams, James Verbsky, Wendy Blumenschein, Svetlana Sadekova, Eddie Bowman, Christie Ballantyne, Casey Weaver, David A Serody, Benjamin Vincent, Jonathan Serody, Daniel J Cua, William R Drobyski.   

Abstract

Damage to the gastrointestinal tract is a major cause of morbidity and mortality in graft-versus-host disease (GVHD) and is attributable to T cell-mediated inflammation. In this work, we identified a unique CD4+ T cell population that constitutively expresses the β2 integrin CD11c and displays a biased central memory phenotype and memory T cell transcriptional profile, innate-like properties, and increased expression of the gut-homing molecules α4β7 and CCR9. Using several complementary murine GVHD models, we determined that adoptive transfer and early accumulation of β2 integrin-expressing CD4+ T cells in the gastrointestinal tract initiated Th1-mediated proinflammatory cytokine production, augmented pathological damage in the colon, and increased mortality. The pathogenic effect of this CD4+ T cell population critically depended on coexpression of the IL-23 receptor, which was required for maximal inflammatory effects. Non-Foxp3-expressing CD4+ T cells produced IL-10, which regulated colonic inflammation and attenuated lethality in the absence of functional CD4+Foxp3+ T cells. Thus, the coordinate expression of CD11c and the IL-23 receptor defines an IL-10-regulated, colitogenic memory CD4+ T cell subset that is poised to initiate inflammation when there is loss of tolerance and breakdown of mucosal barriers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27500496      PMCID: PMC5004941          DOI: 10.1172/JCI80874

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Regulatory T cell development in the absence of functional Foxp3.

Authors:  Wen Lin; Dipica Haribhai; Lance M Relland; Nga Truong; Marc R Carlson; Calvin B Williams; Talal A Chatila
Journal:  Nat Immunol       Date:  2007-02-02       Impact factor: 25.606

Review 2.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

3.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

Authors:  Holm H Uhlig; Brent S McKenzie; Sophie Hue; Claire Thompson; Barbara Joyce-Shaikh; Renata Stepankova; Nicolas Robinson; Sofia Buonocore; Helena Tlaskalova-Hogenova; Daniel J Cua; Fiona Powrie
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

Review 4.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.

Authors:  Rupali Das; Xiao Chen; Richard Komorowski; Martin J Hessner; William R Drobyski
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

7.  CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.

Authors:  H I McFarland; S R Nahill; J W Maciaszek; R M Welsh
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

8.  Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia.

Authors:  Hong Zheng; Catherine Matte-Martone; Dhanpat Jain; Jennifer McNiff; Warren D Shlomchik
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

Authors:  Jason R Chan; Wendy Blumenschein; Erin Murphy; Caroline Diveu; Maria Wiekowski; Susan Abbondanzo; Linda Lucian; Richard Geissler; Scott Brodie; Alexa B Kimball; Daniel M Gorman; Kathleen Smith; Rene de Waal Malefyt; Robert A Kastelein; Terrill K McClanahan; Edward P Bowman
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

10.  The UCSC Genome Browser database: 2014 update.

Authors:  Donna Karolchik; Galt P Barber; Jonathan Casper; Hiram Clawson; Melissa S Cline; Mark Diekhans; Timothy R Dreszer; Pauline A Fujita; Luvina Guruvadoo; Maximilian Haeussler; Rachel A Harte; Steve Heitner; Angie S Hinrichs; Katrina Learned; Brian T Lee; Chin H Li; Brian J Raney; Brooke Rhead; Kate R Rosenbloom; Cricket A Sloan; Matthew L Speir; Ann S Zweig; David Haussler; Robert M Kuhn; W James Kent
Journal:  Nucleic Acids Res       Date:  2013-11-21       Impact factor: 16.971

View more
  16 in total

1.  Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.

Authors:  Jennifer Schloss; Riyasat Ali; Jeffrey Babad; Ignacio Guerrero-Ros; Jillamika Pongsachai; Li-Zhen He; Tibor Keler; Teresa P DiLorenzo
Journal:  Immunohorizons       Date:  2019-06-26

Review 2.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Authors:  James Lm Ferrara; Christopher M Smith; Julia Sheets; Pavan Reddy; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

3.  Newly found arsons ignite the fire of gut GVHD.

Authors:  Defu Zeng
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

4.  Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity.

Authors:  Lan Luo; Yuhong Chen; Xiao Chen; Yongwei Zheng; Vivian Zhou; Mei Yu; Robert Burns; Wen Zhu; Guoping Fu; Juan C Felix; Christopher Hartley; Alisa Damnernsawad; Jing Zhang; Renren Wen; Williams R Drobyski; Chunji Gao; Demin Wang
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

5.  Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.

Authors:  Kate H Gartlan; Motoko Koyama; Katie E Lineburg; Karshing Chang; Kathleen S Ensbey; Rachel D Kuns; Andrea S Henden; Luke D Samson; Andrew D Clouston; Angel F Lopez; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood Adv       Date:  2019-10-08

6.  Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease.

Authors:  Jooho Chung; Vedran Radojcic; Eric Perkey; Timothy J Parnell; Yashar Niknafs; Xi Jin; Ann Friedman; Nathalie Labrecque; Bruce R Blazar; Todd V Brennan; Christian W Siebel; Ivan Maillard
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

7.  Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.

Authors:  Clint Piper; Vivian Zhou; Richard Komorowski; Aniko Szabo; Benjamin Vincent; Jonathan Serody; Maria-Luisa Alegre; Brian T Edelson; Reshma Taneja; William R Drobyski
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

8.  STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.

Authors:  Yongxia Wu; Chih-Hang Anthony Tang; Corey Mealer; David Bastian; M Hanief Sofi; Linlu Tian; Steven Schutt; Hee-Jin Choi; Taylor Ticer; Mengmeng Zhang; Xiaohui Sui; Lei Huang; Andrew L Mellor; Chih-Chi Andrew Hu; Xue-Zhong Yu
Journal:  Cell Mol Immunol       Date:  2021-01-26       Impact factor: 11.530

9.  Targeting Cytokines in GVHD Therapy.

Authors:  Sandeep Kumar; Hemn Mohammadpour; Xuefang Cao
Journal:  J Immunol Res Ther       Date:  2017-06-28

10.  Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.

Authors:  Vera Buchele; Benjamin Abendroth; Maike Büttner-Herold; Tina Vogler; Johanna Rothamer; Sakhila Ghimire; Evelyn Ullrich; Ernst Holler; Markus F Neurath; Kai Hildner
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.